Patients Views & Analysis

Views & Analysis

Patients

One important way that pharma companies can deliver true patient advocacy is by bringing cross-functional experience to the table.

Patients

Cary Claiborne, CEO of Adial Pharmaceuticals, discusses his company’s bet on a precision treatment for AUD.

Patients

The rising cost of drugs in 2025 was driven by several factors, including inflation, supply chain issues, and the demand for specialty drugs.

Patients

Is patient-centred trial design becoming a strategic advantage for mid-size pharma, helping cut risk, improve timelines, and engage patients?

Patients

Pharmaceutical manufacturers have begun, albeit tentatively, to acknowledge and respond to evolving dietary sensibilities.

Patients

NHS waiting lists are like fires that everyone is frantically trying to put out. But however much water we pour on it, the flames keep roaring.